This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.


We welcome your feedback, which will help improve this site.

Feedback form

Are cannabis-based products effective for medicinal use?


Researchers are being asked to investigate the effectiveness of cannabis-based products for medicinal use under a new NIHR themed research call.

Investigators can submit their research proposals to look at the use of products for difficult-to-treat epilepsy or other disorders unresponsive to existing treatments.

Applications should meet all the professional and legal requirements within which cannabis-based products for medicinal use may be prescribed and lead to robust clinical evidence that will inform practice.

The invitation for applications comes following a review of the Chief Medical Officer, Professor Dame Sally Davies, to the UK Government. The review considered a range of evidence from a number of international sources and recommended that the whole class of cannabis based medicinal products be moved out of Schedule 1 of the Misuse of Drugs Regulations.

Following the review, the Home Office announced that specialist clinicians would be able to legally prescribe cannabis-derived medicinal products by autumn.

For further details about this research call visit the themed calls page.